Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Muhammad H. Shahzad
Observed name:
Shahzad, Muhammad H
Institutions:
Montreal General Hospital,
Research Institute of the McGill University Health Centre,
McGill University
Observed institutions:
Montreal General Hospital,
Research Institute of the McGill University Health Centre,
McGill University
ORCID:
0000-0003-0414-0345
Observed ORCID:
0000-0003-0414-0345
OpenAlex ID:
A5036750413
Neoadjuvant Chemoimmunotherapy for NSCLC
2024
·
Mark Sorin
, Connor Prosty
, et al.
·
JAMA Oncology
·
239
PDF
Neutrophil Extracellular Traps in Cancer Therapy Resistance
2022
·
Muhammad H. Shahzad
, Lixuan Feng
, et al.
·
Cancers
·
71
PDF
Neutrophil extracellular traps in cancer
2025
·
Muhammad H. Shahzad
, Roni F. Rayes
, et al.
·
Nature reviews. Cancer
·
40
Perioperative Immunotherapy for Node-Negative Non-Small Cell Lung Cancer—Current Evidence and Future Directions
2024
·
Muhammad H. Shahzad
, Jonathan D. Spicer
, et al.
·
The Annals of Thoracic Surgery
·
6
Visualizing NETosis Using a Novel Neutrophil Extracellular Trap-Specific Marker
2023
·
Meghan L. De Meo
, Muhammad H. Shahzad
, et al.
·
Methods in molecular biology
·
6
KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma
2025
·
Meghan L. De Meo
, Joseph Seitlinger
, et al.
·
Clinical Lung Cancer
·
2
Abstract B020: NETosis-specific clipped histone H3 is a novel biomarker of response to neoadjuvant chemo-immunotherapy in resectable lung cancer
2025
·
Muhammad H. Shahzad
, Alberto Cruz-Bermudez
, et al.
·
Cancer Immunology Research
Show more works
View as search
Works count:
8
Citation count:
365
H-index:
5
I10-index:
3
Year
Topic
Type
